{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T15:45:22Z","timestamp":1774453522681,"version":"3.50.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2019,7,12]],"date-time":"2019-07-12T00:00:00Z","timestamp":1562889600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,12]],"date-time":"2019-07-12T00:00:00Z","timestamp":1562889600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s00417-019-04413-z","type":"journal-article","created":{"date-parts":[[2019,7,12]],"date-time":"2019-07-12T19:02:28Z","timestamp":1562958148000},"page":"2323-2328","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Breakdown of the blood-eye barrier in choroidal melanoma after proton beam radiotherapy"],"prefix":"10.1007","volume":"257","author":[{"given":"Annette","family":"Hager","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Friederike","family":"Meissner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aline\u2013Isabel","family":"Riechardt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theresa","family":"Bonaventura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"L\u00f6wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1782-7376","authenticated-orcid":false,"given":"Jens","family":"Heufelder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonia M.","family":"Joussen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,7,12]]},"reference":[{"key":"4413_CR1","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1001\/archopht.124.12.1684","volume":"124","author":"Collaborative Ocular Melanoma Study Group","year":"2006","unstructured":"Collaborative Ocular Melanoma Study Group (2006) The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: V. Twelve-year mortality rates and prognostic factors: COMS report No. 28. Arch Ophthalmol 124:1684\u20131693","journal-title":"Arch Ophthalmol"},{"key":"4413_CR2","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.ajo.2015.06.017","volume":"160","author":"I Seibel","year":"2015","unstructured":"Seibel I, Cordini D, Rehak M et al (2015) Local recurrence after primary proton beam therapy in uveal melanoma: risk factors, retreatment approaches, and outcome. Am J Ophthalmol 160:628\u2013636","journal-title":"Am J Ophthalmol"},{"key":"4413_CR3","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.ajo.2017.03.027","volume":"178","author":"Ira Seibel","year":"2017","unstructured":"Seibel I, Riechardt AI, Heufelder J et al (2017) Adjuvant ab interno tumor treatment after proton beam irradiation. Am J Ophthalmol. \nhttps:\/\/doi.org\/10.1016\/j.ajo.2017.03.027","journal-title":"American Journal of Ophthalmology"},{"key":"4413_CR4","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1159\/000365333","volume":"1","author":"I Seibel","year":"2015","unstructured":"Seibel I, Cordini D, Willerding G et al (2015) Endodrainage, tumor photocoagulation, and silicone oil tamponade for primary exudative retinal detachment due to choroidal melanoma persisting after proton beam therapy. Ocul Oncol Pathol 1:24\u201333","journal-title":"Ocul Oncol Pathol"},{"key":"4413_CR5","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1007\/s00417-016-3310-5","volume":"254","author":"AI Riechardt","year":"2016","unstructured":"Riechardt AI, Cordini D, Rehak M et al (2016) Trabeculectomy in patients with uveal melanoma after proton beam therapy. Graefes Arch Clin Exp Ophthalmol 254:1379\u20131385","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"4413_CR6","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1136\/bjo.85.11.1305","volume":"85","author":"L Lumbroso","year":"2001","unstructured":"Lumbroso L, Desjardins L, Levy C et al (2001) Intraocular inflammation after proton beam irradiation for uveal melanoma. Br J Ophthalmol 85:1305\u20131308","journal-title":"Br J Ophthalmol"},{"key":"4413_CR7","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s10384-016-0488-3","volume":"61","author":"M Sawa","year":"2017","unstructured":"Sawa M (2017) Laser flare-cell photometer: principle and significance in clinical and basic ophthalmology. Jpn J Ophthalmol 61:21\u201342","journal-title":"Jpn J Ophthalmol"},{"key":"4413_CR8","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1088\/0031-9155\/47\/4\/304","volume":"47","author":"B Dobler","year":"2002","unstructured":"Dobler B, Bendl R (2002) Precise modelling of the eye for proton therapy of intraocular tumours. Phys Med Biol 47:593\u2013613","journal-title":"Phys Med Biol"},{"key":"4413_CR9","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1088\/0031-9155\/46\/3\/304","volume":"46","author":"K Pfeiffer","year":"2001","unstructured":"Pfeiffer K, Bendl R (2001) Real-time dose calculation and visualization for the proton therapy of ocular tumours. Phys Med Biol 46:671\u2013686","journal-title":"Phys Med Biol"},{"key":"4413_CR10","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/eye.2012.249","volume":"27","author":"C Groenewald","year":"2013","unstructured":"Groenewald C, Konstanidis L, Damato B (2013) Effects of radiotherapy on uveal melanomas and adjacent tissues. Eye 27:163\u2013171","journal-title":"Eye"},{"key":"4413_CR11","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.ophtha.2014.12.034","volume":"122","author":"A Mashayekhi","year":"2015","unstructured":"Mashayekhi A, Sch\u00f6nbach E, Shields CL, Shields JA (2015) Early subclinical macular edema in eyes with uveal melanoma: association with future cystoid macular edema. Ophthalmology 122:1023\u20131029","journal-title":"Ophthalmology"},{"key":"4413_CR12","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1001\/archopht.124.10.1428","volume":"124","author":"GS Missotten","year":"2006","unstructured":"Missotten GS, Notting IC, Schlingemann RO et al (2006) Vascular endothelial growth factor a in eyes with uveal melanoma. Arch Ophthalmol 124:1428\u20131434","journal-title":"Arch Ophthalmol"},{"key":"4413_CR13","doi-asserted-by":"publisher","first-page":"6748","DOI":"10.1167\/iovs.12-10123","volume":"53","author":"N Nagarkatti-Gude","year":"2012","unstructured":"Nagarkatti-Gude N, Bronkhorst IHG, van Duinen SG et al (2012) Cytokines and chemokines in the vitreous fluid of eyes with uveal melanoma. Invest Ophthalmol Vis Sci 53:6748\u20136755","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4413_CR14","doi-asserted-by":"publisher","first-page":"399","DOI":"10.5301\/ejo.5000236","volume":"23","author":"A Mashayekhi","year":"2013","unstructured":"Mashayekhi A, Tuncer S, Shields CL, Shields JA (2013) Tumor-related lipid exudation and associated tumor-related complications after plaque radiotherapy of posterior uveal melanoma. Eur J Ophthalmol 23:399\u2013409","journal-title":"Eur J Ophthalmol"},{"key":"4413_CR15","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.ophtha.2009.10.018","volume":"117","author":"A Mashayekhi","year":"2010","unstructured":"Mashayekhi A, Tuncer S, Shields CL, Shields JA (2010) Tumor-related lipid exudation after plaque radiotherapy of choroidal melanoma: the role of Bruch\u2019s membrane rupture. Ophthalmology 117:1013\u20131023","journal-title":"Ophthalmology"},{"key":"4413_CR16","first-page":"2085","volume":"42","author":"T Kivel\u00e4","year":"2001","unstructured":"Kivel\u00e4 T, Eskelin S, M\u00e4kitie T et al (2001) Exudative retinal detachment from malignant uveal melanoma: predictors and prognostic significance. Invest Ophthalmol Vis Sci 42:2085\u20132093","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"4413_CR17","doi-asserted-by":"publisher","first-page":"596","DOI":"10.5301\/ejo.5000940","volume":"27","author":"Ariane Malcl\u00e8s","year":"2017","unstructured":"Malcles A, Nguyen AM, Mathis T et al (2017) Intravitreal dexamethasone implant (Ozurdex) for exudative retinal detachment after proton beam therapy for choroidal melanoma. Eur J Ophthalmol. \nhttps:\/\/doi.org\/10.5301\/ejo.5000940","journal-title":"European Journal of Ophthalmology"},{"key":"4413_CR18","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1136\/bjophthalmol-2013-304501","volume":"98","author":"L Konstantinidis","year":"2014","unstructured":"Konstantinidis L, Groenewald C, Coupland SE et al (2014) Trans-scleral local resection of toxic choroidal melanoma after proton beam radiotherapy. Br J Ophthalmol 98:775\u2013779","journal-title":"Br J Ophthalmol"},{"key":"4413_CR19","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/S0002-9394(02)02292-4","volume":"136","author":"DH Char","year":"2003","unstructured":"Char DH, Bove R, Phillips TL (2003) Laser and proton radiation to reduce uveal melanoma-associated exudative retinal detachment. Am J Ophthalmol 136:180\u2013182","journal-title":"Am J Ophthalmol"},{"key":"4413_CR20","doi-asserted-by":"publisher","first-page":"796","DOI":"10.5301\/EJO.2011.6477","volume":"21","author":"H Newman","year":"2011","unstructured":"Newman H, Finger PT, Chin KJ et al (2011) Systemic bevacizumab (Avastin) for exudative retinal detachment secondary to choroidal melanoma. Eur J Ophthalmol 21:796\u2013801","journal-title":"Eur J Ophthalmol"},{"key":"4413_CR21","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1001\/archopht.1979.01020020053012","volume":"97","author":"DJ Fraser","year":"1979","unstructured":"Fraser DJ, Font RL (1979) Ocular inflammation and hemorrhage as initial manifestations of uveal malignant melanoma. Arch Ophthalmol 97:1311\u20131314","journal-title":"Arch Ophthalmol"},{"key":"4413_CR22","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1159\/000027418","volume":"213","author":"NX Nguyen","year":"1992","unstructured":"Nguyen NX, K\u00fcchle M, Naumann GOH (1992) Tumor growth of a choroidal malignant melanoma and aqueous flare. Ophthalmologica 213:194\u2013196","journal-title":"Ophthalmologica"},{"key":"4413_CR23","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/S0002-9394(14)70015-7","volume":"117","author":"M K\u00fcchle","year":"1994","unstructured":"K\u00fcchle M, Nguyen NX, Naumann GO (1994) Quantitative assessment of the blood-aqueous barrier in human eyes with malignant or benign uveal tumors. Am J Ophthalmol 117:521\u2013528","journal-title":"Am J Ophthalmol"},{"key":"4413_CR24","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1136\/bjo.79.4.354","volume":"90","author":"AP Castella","year":"1995","unstructured":"Castella AP, Bercher L, Zografos L et al (1995) Study of the blood-aqueous barrier in choroidal melanoma. Br J Ophthalmol 90:354\u2013357","journal-title":"Br J Ophthalmol"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-019-04413-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-019-04413-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-019-04413-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,10]],"date-time":"2020-07-10T23:06:09Z","timestamp":1594422369000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-019-04413-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,12]]},"references-count":24,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["4413"],"URL":"https:\/\/doi.org\/10.1007\/s00417-019-04413-z","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,12]]},"assertion":[{"value":"4 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"IRB approval was obtained. All procedures performed in studies involving human participants were in accordance with the ethical standards of the IRB Charit\u00e9\u2013Universit\u00e4tsmedizin Berlin (EA4\/095\/15) and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Informed consent from all patients was obtained.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and informed consent"}}]}}